POINT Biopharma Global Inc.

POINT Biopharma Global Inc. filed an S-1 registration statement on July 30, 2021, under the SPAC ticker RACA, corresponding to Research Alliance Corp. II, a blank-check company that completed its IPO in 2021. The filing was made in connection with the proposed business combination that would bring POINT Biopharma, a clinical-stage radiopharmaceutical company focused on targeted cancer therapies, into the public markets. Research Alliance Corp. II was structured around the healthcare and life sciences sector. The de-SPAC transaction represented POINT Biopharma's path to a Nasdaq listing under the ticker PNT. Visit SpacDesk and sign up for full data, filings history, and deal analytics on this and every active SPAC transaction.